ABIVAX Société Anonyme (EPA:ABVX)
France flag France · Delayed Price · Currency is EUR
113.40
-0.10 (-0.09%)
May 29, 2026, 5:36 PM CET

ABIVAX Société Anonyme Revenue

ABIVAX Société Anonyme had revenue of 1.34M EUR in the quarter ending March 31, 2026, with 35.21% growth. This brings the company's revenue in the last twelve months to 4.92M, down -59.82% year-over-year. In the year 2025, ABIVAX Société Anonyme had annual revenue of 4.57M, down -63.22%.

Revenue (ttm)
4.92M
Revenue Growth
-59.82%
P/S Ratio
1,836.86
Revenue / Employee
61.50K
Employees
69
Market Cap
9.04B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.57M-7.86M-63.22%
Dec 31, 202412.43M7.85M171.67%
Dec 31, 20234.57M69.00K1.53%
Dec 31, 20224.51M302.00K7.19%
Dec 31, 20214.20M4.19M29,921.43%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Valneva SE156.33M
Genfit65.43M
Cellectis65.14M
Nanobiotix32.59M
MedinCell32.44M
Innate Pharma9.01M
Transgene7.21M
Inventiva6.76M
Revenue Rankings